Although results from in-vitro studies have suggested an anti-tumor effect of SET7/9 through positive regulation of p53, the indispensible role of SET7/9 in the stabilization of p53 and regulation of p53-mediated DNA damage response is questioned by vivo experiments. Here, TP53 is linked to neoplasm.